Research
Energy balance
Cagrilintide monotherapy weight loss was comparable to semaglutide.
Cagrilintide may be a viable alternative to semaglutide for weight management in obese patients.
StrongSupportsmedium confidence
Cagrilintide monotherapy weight loss was comparable to semaglutide.
Why this rating
Based on a systematic review and meta-analysis of randomized controlled trials.
Source
Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti‐Obesity Medications: A Systematic Review, Meta‐Analysis and Meta‐Regression
Muhammad Ahmed et al. · Diabetes Obesity and Metabolism · 2026
Meta-analysis
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →